Quarterly report pursuant to Section 13 or 15(d)

Summary of Stock Options Activity (Details)

v3.24.1.1.u2
Summary of Stock Options Activity (Details) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]    
Number of Shares, Beginning Balance 139,840  
Weighted Average Exercise Price, Beginning Balance $ 46.09  
Weighted Average Grant Date Fair Value, Beginning $ 42.34  
Weighted Average Remaining Contractual Term (Years), Beginning   8 years 2 months 1 day
Aggregate Intrinsic Value, Beginning Balance  
Number of Shares, Granted  
Weighted Average Exercise Price, Granted  
Weighted Average Grant Date Fair Value, Granted  
Number of Shares, Exercised  
Weighted Average Exercise Price, Exercised  
Weighted Average Grant Date Fair Value, Exercised  
Number of Shares, Forfeited  
Weighted Average Exercise Price, Forfeited  
Weighted Average Grant Date Fair Value, Forfeited  
Number of Shares, Canceled/Expired  
Weighted Average Exercise Price, Canceled/Expired  
Weighted Average Grant Date Fair Value, Canceled/Expired  
Number of Shares, Ending Balance 139,840 139,840
Weighted Average Exercise Price, Ending Balance $ 46.09 $ 46.09
Weighted Average Grant Date Fair Value, Ending $ 42.34 $ 42.34
Weighted Average Remaining Contractual Term (Years), Ending 7 years 11 months 1 day  
Aggregate Intrinsic Value, Ending Balance
Number of Shares, Exercisable 47,286  
Weighted Average Exercise Price, Exercisable $ 56.44  
Weighted Average Grant Date Fair Value, Exercisable $ 51.49  
Weighted Average Remaining Contractual Term (Years), Exercisable 7 years 2 months 23 days  
Aggregate Intrinsic Value, Exercisable